Key Sessions, Embargo Exceptions, and Institutional Press Releases
2024 ANNUAL MEETING SCHEDULE
ASH Annual Meeting Schedule-at-a-Glance
Highlighted below are some sessions that may be of press interest. All times are listed in Pacific time.
INSTITUTIONAL PRESS RELEASES
The press releases in the ASH media portal were submitted by institutions and companies and are being shared as a service to reporters covering the annual meeting. Each press release was written solely by the submitting institution or company. While ASH staff have confirmed the embargo times and abstract numbers, the Society is not responsible for the accuracy of the content.
Accessed via the ASH Media Portal.
Password: @SHM3dia
EXCEPTION TO EMBARGO POLICY - SEC REGULATIONS
In certain situations, a publicly traded company may be advised by legal counsel that certain data from the abstract must be disclosed to the public prior to the public release of the abstracts in order to comply with requirements of the U.S. Securities and Exchange Commission (SEC) or a corresponding regulatory body in the country where the company's stock is traded. Under such extenuating circumstances, ASH may grant an exception to its embargo rules and allow the company to release limited top line data (i.e., general findings with no additional analysis, commentary, investigator quotes, etc.) from the abstract without jeopardizing its eligibility for presentation at the annual meeting.
As outlined in the Embargo Policy, ASH evaluates these requests on a case-by-case basis. As of 11/13/24, the following abstracts were granted embargo exceptions:
| Abstract | Contact | Date |
| Abstract #1031 | Maryam Abdull-Kareem, Arcellx ([email protected]) | December 5, 2024 |
| Abstract #4825 | Maryam Abdull-Kareem, Arcellx ([email protected]) | December 5, 2024 |
| Abstract #772 | Kate Tomasco, GSK, ([email protected]) | November 11, 2024 |
| Abstract #4775 | Marianne Jenal-Eyholzer, Molecular Partners ([email protected]) | December 8, 2024 at 9:00 a.m. PT |
DISCLAIMER
The Society reserves the right to bar, from this and future annual meetings, anyone who violates our press policies, including those who attempt to obtain advertising or subscriptions from any exhibitor or registrant, who deliberately promote the marketing objectives of a single company or institution, or who misuse media privileges to engage in activities other than journalistic pursuits.